Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

curative ventures

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$116M
Portfolio companies 3
Rounds per year 0.21
Lead investments 1
Exits 3
Key employees 1
Stages of investment
Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

The main department of described VC is located in the Dallas. The company was established in North America in United States.

Among the most popular portfolio startups of the fund, we may highlight ITeos Therapeutics, TCR2. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the location of its establishment and the land of its numerous investments - Belgium. Among the most successful fund investment fields, there are Medical, Medical Device.

The standard case for the fund is to invest in rounds with more than 10 partakers. Despite the curative ventures, startups are often financed by The Column Group, Remeditex Ventures, UBS Asset Management. The meaningful sponsors for the fund in investment in the same round are MPM Capital, 6 Dimensions Capital, Vida Ventures.

The top amount of exits for fund were in 2019. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. This curative ventures works on 38 percentage points more the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually.

Besides them, we counted 1 critical employee of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of curative ventures:
Typical Co-investors
curative ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after curative ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Brookwood Financial Partners Beverly, Massachusetts, United States
Chengdu Kunde Touzi Chengdu, China, Sichuan
Columbia Venture Competition -
High Ground Capital Beijing, Beijing, China
Huazhang Universe Media Investment Holding Group China, Guangdong, Jiangxi
OJIT Ventures Investment Islas Baleares, Palma De Mallorca, Spain
Optidob Bloemendaal, Noord-Holland, The Netherlands
Picea Capital Germany, Hamburg
Qatar Science & Technology Park Ad Dawhah, Doha, Qatar
Qiuling Capital Beijing, Beijing, China
Shenzhen Sidu Kongjian Touzi Co., Ltd. China, Guangdong, Shenzhen
Socomore Ventures -
Talis Capital England, London, United Kingdom
The Linhui Fund Changning, China, Shanghai
The Panther Opportunity Fund Chicago, Illinois, United States
Tokyo Ohka Kogyo Japan, Kanagawa Prefecture, Kawasaki
Traverse Venture Partners District of Columbia, United States, Washington
Worldpay England, London, United Kingdom
Yuanning Huizhi Investment Management China, Hangzhou, Zhejiang
Zhuhai Keming -

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ITeos Therapeutics

Biotechnology
Health Care
Medical
$75M20 Jun 2018 Cambridge, Massachusetts, United States

TCR2

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
$125M21 Mar 2018 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent curative ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 3
Average round size 116M
Rounds per year 0.21
Peak activity year 2018
Lead investments 1
Exits 3
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ITeos Therapeutics

Biotechnology
Health Care
Medical
$75M20 Jun 2018 Cambridge, Massachusetts, United States

TCR2

Biotechnology
Health Care
Life Science
Medical
Pharmaceutical
Therapeutics
$125M21 Mar 2018 Cambridge, Massachusetts, United States
Crunchbase icon

Content report

The following text will be sent to our editors: